COMP <GO>
EMBC vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Embecta Corp. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: EMBC 4
— JNJ 7
■ METRIC PARITY
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
options-implied-move
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMBC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.60% | 67.90% | -5.30 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.50% | 25.50% | +10.00 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 18.5x | -12.40 | EMBC | /valuation <GO> |
| Free Cash Flow Yield | — | 2.97% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 22.40% | 34.70% | -12.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 28.50% | -19.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | -3.80% | 6.00% | -9.80 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.42% | 0.00% | +9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.2 | 62.1 | -9.91 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | 23.0x | -19.40 | EMBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.7M | $662.49B | -$662.12B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMBC REV | JNJ REV | EMBC GROSS % | JNJ GROSS % | EMBC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $94.19B | 62.6% | 67.9% | $182.4M | $19.70B |
| FY 2024 | $1.12B | $88.82B | 65.5% | 69.1% | $19.9M | $19.84B |
| FY 2023 | $1.12B | $85.16B | — | — | $67.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
JNJ // BETA 1.08